RecruitingPhase 2NCT06696183
Gilteritinib in Combination With Venetoclax and Azacitidine for AML Patients With FLT3 Mutations Ineligible for Intensive Treatment
Studying Acute graft versus host disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Technische Universität Dresden
- Intervention
- Gilteritinib (GILT)(drug)
- Enrollment
- 60 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2030
Study locations (1)
- Technische Universität Dresden, Dresden, Germany
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06696183 on ClinicalTrials.govOther trials for Acute graft versus host disease
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07295483Predictors of Long-Term Evolution in Long COVID; 4-Year Follow-Up. (BioICOPER Follow-up Study)Instituto de Investigación Biomédica de Salamanca
- RECRUITINGPHASE3NCT07253181Tenecteplase Before Interhospital Transfer for EVT in Acute Anterior Circulation LVO at 4.5-24 HoursXuanwu Hospital, Beijing
- RECRUITINGNANCT07467694Postnatal Exercise to Activate Baby's Brown FatJoslin Diabetes Center
- RECRUITINGNCT07435805Long-Term Health Effects of Previous COVID-19 in Patients Undergoing Preoperative Anesthesia EvaluationElazıg Fethi Sekin Sehir Hastanesi
- RECRUITINGPHASE2NCT07334379Interleukin-6 Guided Treatment With Dexamethasone or Tocilizumab in Patients Hospitalized With Acute Respiratory Symptoms - a Feasibility StudyLorenzo delSorbo
- ENROLLING BY INVITATIONPHASE1, PHASE2NCT07163299Intra-arterial Selective Hypothermic Magnesium Sulfate Infusion in Combination With Endovascular Thrombectomy in Acute Ischemic StrokeCapital Medical University
- RECRUITINGNANCT06918964TaVNS for Acute Intracerebral HemorrhageBeijing Tiantan Hospital
- RECRUITINGNCT07548580Physical Mobilisation to Acquired Brain Injury Patients in Intensive Care Units: a Prospective Cohort StudyRigshospitalet, Denmark